Encouraging news from researchers at Fred Hutchinson Cancer Center in Washington recently showed that an experimental gene therapy for herpes simplex virus infections may suppress the amount of transmissible virus.
Drs. Keith Jerome and Martine Aubert, the virologists leading the research effort, reported the innovative treatment dramatically reduced or even eliminated viral shedding in treated mice compared to controls.
Herpes Gene Therapy Further Refined in Mice
Vaccines Offer the Best Protection Against Severe Influenza
With a potentially severe respiratory season ahead, data released today by the National Foundation for Infectious Diseases (NFID) indicates many Americans are unaware of their health risks.
The 2022 National Survey: Attitudes about Influenza and Pneumococcal Disease, and the Impacts of COVID-19, was released by the NFID on October 4, 2022, indicating only 49% of adults plan to get an influenza vaccination during the 2022-2023 flu season.
Vaccines Offer the Best Protection Against Severe Influenza
With a potentially severe respiratory season ahead, data released today by the National Foundation for Infectious Diseases (NFID) indicates many Americans are unaware of their health risks.
The 2022 National Survey: Attitudes about Influenza and Pneumococcal Disease, and the Impacts of COVID-19, was released by the NFID on October 4, 2022, indicating only 49% of adults plan to get an influenza vaccination during the 2022-2023 flu season.
Pirfenidone Promising for RA-Linked Interstitial Lung Disease
Phase 2 trial terminated early, underpowered to meet primary end point, but limited results suggest pirfenidone may slow progression of RA-ILD